What is Amgen's work in process?

Amgen (AMGN) reported work in process of $3.43B in Q1 2026.

How has Amgen's work in process changed year-over-year?

Amgen's work in process decreased by 13.5% year-over-year, from $3.96B to $3.43B.

What is the long-term trend for Amgen's work in process?

Over 5 years (2020 to 2025), Amgen's work in process has grown at a 7.0% compound annual growth rate (CAGR), from $2.44B to $3.43B.

Current Assets

Work in process

Amgen Work in process increased by 0.0% to $3.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.5%, from $3.96B to $3.43B. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 7.0% CAGR.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

First reportedQ4 2015

Last reportedQ1 2026Apr 30, 2026

Parent metricInventories

Metric ID: inv_work_in_progress

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$2.44B	$2.31B	$2.37B	$2.58B	$2.76B	$2.93B	$3.1B	$2.98B	$3.05B	$2.99B	$5.75B	$5.27B	$4.48B	$4.34B	$4.12B	$3.96B	$3.66B	$3.56B	$3.43B	$3.43B
QoQ Change	—	-5.3%	+2.3%	+9.1%	+7.0%	+6.0%	+5.8%	-3.9%	+2.4%	-1.8%	+92.1%	-8.3%	-15.1%	-3.1%	-5.0%	-3.9%	-7.6%	-2.8%	-3.7%	+0.0%
YoY Change	—	—	—	—	+13.1%	+26.6%	+30.9%	+15.3%	+10.3%	+2.2%	+85.5%	+77.0%	+46.9%	+45.0%	-28.3%	-24.8%	-18.3%	-18.1%	-16.9%	-13.5%
% of Inventories	59.4%	55.7%	57.9%	58.5%	60.7%	61.6%	62.8%	59.4%	61.2%	59.5%	60.4%	60.4%	56.0%	58.9%	58.9%	58.9%	55.6%	56.0%	55.0%	55.4%
Share Change	—	-3.7pp	+2.2pp	+0.6pp	+2.1pp	+0.9pp	+1.3pp	-3.4pp	+1.8pp	-1.7pp	+0.8pp	+0.0pp	-4.4pp	+3.0pp	-0.1pp	-0.0pp	-3.3pp	+0.5pp	-1.0pp	+0.4pp

Range$2.31B – $5.75B

CAGR+7.4%

Avg YoY Growth+14.6%

Median YoY Growth+11.7%

Work in process at Other Companies

Eli LillyLLY View metric

PfizerPFE View metric

Regeneron PharmaceuticalsREGN View metric

AbbVieABBV View metric

AbbottABT View metric

ALN

Alnylam PharmaceuticalsALNY View metric

Frequently Asked Questions

What is Amgen's work in process?: Amgen (AMGN) reported work in process of $3.43B in Q1 2026.
How has Amgen's work in process changed year-over-year?: Amgen's work in process decreased by 13.5% year-over-year, from $3.96B to $3.43B.
What is the long-term trend for Amgen's work in process?: Over 5 years (2020 to 2025), Amgen's work in process has grown at a 7.0% compound annual growth rate (CAGR), from $2.44B to $3.43B.